As of 2024-12-12, the Relative Valuation of Cytosorbents Corp (CTSO) is (12.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Cytosorbents Corp based on Relative Valuation is -1490.8%.
The range of the Relative Valuation is (12.74) - (12.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.3x - 41.4x | 38.7x |
| Forward P/E multiples | 30.3x - 36.1x | 33.0x |
| Fair Price | (12.74) - (12.32) | (12.25) |
| Upside | -1546.1% - -1498.8% | -1490.8% |
| Date | P/E |
| 2024-12-10 | -2.55 |
| 2024-12-09 | -2.58 |
| 2024-12-06 | -2.67 |
| 2024-12-05 | -2.71 |
| 2024-12-04 | -2.83 |
| 2024-12-03 | -2.78 |
| 2024-12-02 | -2.93 |
| 2024-11-29 | -2.84 |
| 2024-11-27 | -2.67 |
| 2024-11-26 | -2.63 |
| 2024-11-25 | -2.72 |
| 2024-11-22 | -2.69 |
| 2024-11-21 | -2.61 |
| 2024-11-20 | -2.68 |
| 2024-11-19 | -2.81 |
| 2024-11-18 | -2.72 |
| 2024-11-15 | -2.62 |
| 2024-11-14 | -2.78 |
| 2024-11-13 | -2.71 |
| 2024-11-12 | -2.84 |
| 2024-11-11 | -2.72 |
| 2024-11-08 | -2.17 |
| 2024-11-07 | -2.64 |
| 2024-11-06 | -2.69 |
| 2024-11-05 | -2.53 |
| 2024-11-04 | -2.55 |
| 2024-11-01 | -2.93 |
| 2024-10-31 | -2.96 |
| 2024-10-30 | -2.96 |
| 2024-10-29 | -2.99 |
| 2024-10-28 | -2.96 |
| 2024-10-25 | -3.05 |
| 2024-10-24 | -3.08 |
| 2024-10-23 | -3.08 |
| 2024-10-22 | -3.05 |
| 2024-10-21 | -3.08 |
| 2024-10-18 | -3.19 |
| 2024-10-17 | -3.31 |
| 2024-10-16 | -3.28 |
| 2024-10-15 | -3.19 |
| 2024-10-14 | -3.22 |
| 2024-10-11 | -3.28 |
| 2024-10-10 | -3.08 |
| 2024-10-09 | -3.31 |
| 2024-10-08 | -3.31 |
| 2024-10-07 | -3.31 |
| 2024-10-04 | -3.49 |
| 2024-10-03 | -3.60 |
| 2024-10-02 | -3.92 |
| 2024-10-01 | -3.95 |